Explore

Reuters Reuters
Novo Nordisk's weight-loss pill boom faces price war test

Novo Nordisk's weight-loss pill boom faces price war test

By Maggie Fick and Stine Jacobsen LONDON/COPENHAGEN, May 5 (Reuters) - Novo Nordisk is seeing brisk early demand for its new weight-loss pill as competition with U.S. rival Eli Lilly intensifies.
Trendline Trendline
Kessler Topaz Meltzer Check, LLP Alerts ImmunityBio Investors of Securities Fraud Class Action

Kessler Topaz Meltzer Check, LLP Alerts ImmunityBio Investors of Securities Fraud Class Action

Kessler Topaz Meltzer Check, LLP Alerts ImmunityBio Investors of Securities Fraud Class Action
Trendline Trendline
ImmunityBio Faces Securities Fraud Lawsuit Over Misleading Cancer Drug Claims

ImmunityBio Faces Securities Fraud Lawsuit Over Misleading Cancer Drug Claims

ImmunityBio Faces Securities Fraud Lawsuit Over Misleading Cancer Drug Claims
Trendline Trendline
Summit Shares Plummet as PD-1/VEGF Drug Fails Early Survival Benchmark

Summit Shares Plummet as PD-1/VEGF Drug Fails Early Survival Benchmark

Summit Shares Plummet as PD-1/VEGF Drug Fails Early Survival Benchmark
Trendline Trendline
ADC Therapeutics Reports Q1 2026 Financial Results and Operational Updates

ADC Therapeutics Reports Q1 2026 Financial Results and Operational Updates

ADC Therapeutics Reports Q1 2026 Financial Results and Operational Updates
Trendline Trendline
Sarepta, Amylyx, and Neumora Prepare for Key Milestones Amidst Q1 Earnings

Sarepta, Amylyx, and Neumora Prepare for Key Milestones Amidst Q1 Earnings

Sarepta, Amylyx, and Neumora Prepare for Key Milestones Amidst Q1 Earnings
Trendline Trendline
Soleno Therapeutics Faces Securities Fraud Allegations in Class Action Lawsuit

Soleno Therapeutics Faces Securities Fraud Allegations in Class Action Lawsuit

Soleno Therapeutics Faces Securities Fraud Allegations in Class Action Lawsuit
Trendline Trendline
North America Biotechnology Market Projected to Reach USD 2168.91 Billion by 2035

North America Biotechnology Market Projected to Reach USD 2168.91 Billion by 2035

North America Biotechnology Market Projected to Reach USD 2168.91 Billion by 2035
Trendline Trendline
Travere Therapeutics Reports Significant Growth in Q1 2026 Financial Results

Travere Therapeutics Reports Significant Growth in Q1 2026 Financial Results

Travere Therapeutics Reports Significant Growth in Q1 2026 Financial Results
Trendline Trendline
Moderna Exceeds Revenue Expectations Despite Litigation Costs Impacting Earnings

Moderna Exceeds Revenue Expectations Despite Litigation Costs Impacting Earnings

Moderna Exceeds Revenue Expectations Despite Litigation Costs Impacting Earnings
Trendline Trendline
Rosen Law Firm Urges Atara Biotherapeutics Investors to Join Securities Class Action Before Deadline

Rosen Law Firm Urges Atara Biotherapeutics Investors to Join Securities Class Action Before Deadline

Rosen Law Firm Urges Atara Biotherapeutics Investors to Join Securities Class Action Before Deadline
Trendline Trendline
Moderna's Revenue Surges in Q1 Due to Strong International Vaccine Sales

Moderna's Revenue Surges in Q1 Due to Strong International Vaccine Sales

Moderna's Revenue Surges in Q1 Due to Strong International Vaccine Sales